Literature DB >> 17908260

A population-based study of urinary symptoms and incontinence: the Canadian Urinary Bladder Survey.

Sender Herschorn1, Jerzy Gajewski, Jane Schulz, Jacques Corcos.   

Abstract

OBJECTIVE: To ascertain the prevalence of lower urinary tract symptoms (LUTS) and urinary incontinence (UI) in Canada, using a cross-Canada telephone survey, as there is a wide discrepancy in the reported prevalence of these conditions. SUBJECTS AND METHODS: A random survey with a standardized questionnaire was conducted to elicit responses from 1000 adults, aged >or= 18 years; the sample was intended to reflect the population census. Data on age, level of education and household income were obtained from all respondents. All participants were questioned about urinary symptoms and daytime and night-time voids. For those who reported more symptoms than one episode of nocturia a more detailed questionnaire was used to ascertain symptom severity and duration.
RESULTS: Data were analysed from 1000 respondents (482 men, mean age 44 years; 518 women, mean age 45 years). Half the respondents (43% of men and 57% of women) reported one or more LUTS, with nocturia the most common, at 36%. Overactive bladder (OAB) symptoms (urgency, with or with no urgency UI, usually with frequency and nocturia) were reported by 13.9% of respondents (13.1% of men and 14.7% of women). UI was reported by 28.8% of women with the 68% of these having stress UI (SUI), followed by mixed UI (MUI) in 21%, and urgency UI (UUI) in 11%. Of the 5.4% of men with UI, 27% had SUI, 15% had MUI, and 58% had UUI. Overall, the prevalence of LUTS increased with age. Respondents reported that symptoms were present for a median of 5 years.
CONCLUSION: LUTS and UI are common in the Canadian population and increase with age. The prevalence in Canada of these conditions is similar to that seen in other countries.

Entities:  

Mesh:

Year:  2007        PMID: 17908260     DOI: 10.1111/j.1464-410X.2007.07198.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  36 in total

1.  A pharmacist's guide to care of adult patients presenting with lower urinary tract symptoms.

Authors:  Geraldine G Gabriel; Ross T Tsuyuki; Adrian Wagg; Kathleen Hunter; Cara Tannenbaum; Cheryl A Sadowski
Journal:  Can Pharm J (Ott)       Date:  2015-09

2.  Economic evaluation of sacral neuromodulation in overactive bladder: A Canadian perspective.

Authors:  Magdy M Hassouna; Hamid Sadri
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

3.  Hormone replacement therapy has no routine role in the management of postmenopausal voiding dysfunction.

Authors:  Lesley K Carr
Journal:  Can Urol Assoc J       Date:  2009-04       Impact factor: 1.862

4.  Botulinum toxin A: First-line therapy for idiopathic detrusor overactivity.

Authors:  Stephen S Steele
Journal:  Can Urol Assoc J       Date:  2011-06       Impact factor: 1.862

5.  Patients with medication-refractory OAB symptoms should be further treated with neuromodulation.

Authors:  Jerzy B Gajewski
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

6.  CUA guideline on adult overactive bladder.

Authors:  Jacques Corcos; Mikolaj Przydacz; Lysanne Campeau; Gary Gray; Duane Hickling; Christiane Honeine; Sidney B Radomski; Lynn Stothers; Adrian Wagg; Frcp Lond
Journal:  Can Urol Assoc J       Date:  2017-05-09       Impact factor: 1.862

7.  2012 update: guidelines for adult urinary incontinence collaborative consensus document for the canadian urological association.

Authors:  Mathieu Bettez; Le Mai Tu; Kevin Carlson; Jacques Corcos; Jerzy Gajewski; Martine Jolivet; Greg Bailly
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

8.  Cost-effectiveness of mirabegron compared to tolterodine ER 4 mg for overactive bladder in Canada.

Authors:  Sender Herschorn; Jameel Nazir; Barbara Ramos; Zalmai Hakimi
Journal:  Can Urol Assoc J       Date:  2017 Mar-Apr       Impact factor: 1.862

Review 9.  Global perspective of treatment failures.

Authors:  Sender Herschorn
Journal:  Can Urol Assoc J       Date:  2013-09       Impact factor: 1.862

10.  Knowledge of pelvic floor disorders amongst immigrant women in Canada.

Authors:  Lina Roa; Sarah Kent; Maryna Yaskina; Jane Schulz; Annick Poirier
Journal:  Int Urogynecol J       Date:  2021-02-23       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.